Lingamneni Anila 4
4 · HAEMONETICS CORP · Filed Sep 13, 2023
Insider Transaction Report
Form 4
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
- Sale
Common Stock
2023-09-11$90.00/sh−2,305$207,450→ 14,495 total
Footnotes (2)
- [F1]Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).
- [F2]This number includes unvested restricted stock units previously reported.